InVitro International, Inc. (IVRO)

Market Cap	1.56M +16.7%
Revenue (ttm)	811.29K -26.6%
Net Income	106.70K +113.9%
EPS	0.00 +100.1%
Shares Out	22.26M
PE Ratio	17.50
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,000
Open	0.0700
Previous Close	0.0700
Day's Range	0.0700 - 0.0700
52-Week Range	0.0315 - 0.1600
Beta	-0.81
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 23, 2026

About InVitro International

InVitro International, Inc. develops test kits for non-animal testing applications in the United States and internationally. Its products include Irritection Assay System, an invitro test, which utilizes the change of relevant macromolecules to predict the ocular and dermal irritancy of chemicals, mixtures, and product formulations; and Corrositex, a non-animal test that determines skin corrosivity based on a biomembrane and chemical detection systems. The company also provides customized technology services for Irritection Assay System install...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1985
• Employees: 16
• Stock Exchange: OTCMKTS
• Ticker Symbol: IVRO

Financial Performance

In fiscal year 2024, InVitro International's revenue was $811,290, an increase of 2.35% compared to the previous year's $792,628. Earnings were $106,704, an increase of 6770.83%.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Sep 10, 2026

Data Sources Report a data error